Status:

COMPLETED

Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2%

Lead Sponsor:

Tehran University of Medical Sciences

Conditions:

Pain

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the effectiveness of diltiazem ointment 2 percent in reducing pain after hemorrhoidectomy.

Detailed Description

Pain after hemorrhoidectomy remains a major postsurgical complication.Therefore pain management in patients is an important goal.Many studies have focused on surgical techniques,preoperative and posto...

Eligibility Criteria

Inclusion

  • Patients with grade 3 or 4 hemorrhoid who underwent Milligan-Morgan surgery.

Exclusion

  • Patients with a history of heart disease, blood pressure, orthostatic hypertension, hemorrhoidal surgery,or those who had previous adverse effect from calcium channel blocker drugs and also those who were pregnant.

Key Trial Info

Start Date :

October 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT00893100

Start Date

October 1 2007

End Date

December 1 2008

Last Update

May 5 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sina General Hospital

Tehran, Tehran Province, Iran